NAA10
N-alpha-acetyltransferase 10 · P41227 · NAA10 on Sugi Atlas →
0 patent compounds predicted against NAA10, 0 high-confidence (nearest known ligand ≥ 0.5)
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to NAA10 by text similarity (a relevance ranking, not an exhaustive list)
Related proteins — ESM-2 sequence neighbours (a NAA10 binder may also engage these)
| Protein | Name | Similarity | |
|---|---|---|---|
| Q9QY36 | — | 1.000 | Q9QY36 → |
| Q2KI14 | — | 1.000 | Q2KI14 → |
| Q9BSU3 | — | 0.997 | Q9BSU3 → |
| Q3UX61 | — | 0.990 | Q3UX61 → |
| Q4V8K3 | — | 0.980 | Q4V8K3 → |
| Q4W5Z4 | — | 0.944 | Q4W5Z4 → |
| DNMT3A | DNA (cytosine-5)-methyltransferase 3A | 0.944 | landscape → |
| Q1LZ53 | — | 0.939 | Q1LZ53 → |
| O88508 | — | 0.938 | O88508 → |
| O13016 | — | 0.931 | O13016 → |
| PTPN1 | Tyrosine-protein phosphatase non-receptor type 1 | 0.931 | landscape → |
| KCNAB1 | Voltage-gated potassium channel subunit beta-1 | 0.926 | landscape → |
| Q9XT31 | — | 0.923 | Q9XT31 → |
| P20417 | — | 0.920 | P20417 → |
| D3Z7P3 | — | 0.916 | D3Z7P3 → |
| GLS | Glutaminase kidney isoform, mitochondrial | 0.911 | landscape → |
| Q7RTP6 | — | 0.911 | Q7RTP6 → |
| P35821 | — | 0.910 | P35821 → |
| Q9DFS6 | — | 0.910 | Q9DFS6 → |
| P13264 | — | 0.909 | P13264 → |
| P48597 | — | 0.909 | P48597 → |
| A0A2R8QFQ6 | — | 0.908 | A0A2R8QFQ6 → |
| WDR26 | WD repeat-containing protein 26 | 0.908 | landscape → |
| Q28528 | — | 0.908 | Q28528 → |
| D1LYT2 | — | 0.907 | D1LYT2 → |
| Q5SRY7 | — | 0.906 | Q5SRY7 → |
| Q9N0T5 | — | 0.906 | Q9N0T5 → |
| GABRB2 | Gamma-aminobutyric acid receptor subunit beta-2 | 0.905 | landscape → |
| P15431 | — | 0.905 | P15431 → |
| Q8CJ19 | — | 0.905 | Q8CJ19 → |